JP Morgan Call 130 ABL 15.11.2024/ DE000JK5YJH1 /
29/07/2024 12:43:50 | Chg.- | Bid22:00:38 | Ask22:00:38 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.013EUR | - | - Bid Size: - |
- Ask Size: - |
ABBOTT LABS | 130.00 - | 15/11/2024 | Call |
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer